United States · FDA National Drug Code directory
Oxybutynin Chloride Extended Release
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43353-284_a9056bad-e15c-4be4-a63c-f51362e2f025
- Product NDC
- 43353-284
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Oxybutynin Chloride
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160309
- Source listing expiry
- 20261231
Source-listed ingredients
- OXYBUTYNIN CHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43353-284-30) · 43353-284-30
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (43353-284-60) · 43353-284-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →